LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Hu, Xiao-Guang"
  2. AU="Zhang, Tianxu"

Search results

Result 1 - 10 of total 21

Search options

  1. Article ; Online: MCC950 Ameliorates Acute Exogenous Lipoid Pneumonia Induced by Sewing Machine Oil in Rats

    Ye, Wan-Ding / Wang, Hua-Min / Xu, Zi-Jin / Liang, Dong-Shi / Huang, Ai-Rong / Xu, Zhi-Wei / Hu, Xiao-Guang / Jin, Yi-Mei

    In vivo (Athens, Greece)

    2023  Volume 37, Issue 6, Page(s) 2533–2542

    Abstract: Background/aim: Acute exogenous lipoid pneumonia (AELP) is a rare disorder caused by intake of lipid formulations and is often underdiagnosed. Meanwhile, the mechanism of AELP is still underlying. MCC950, was previously found to significantly suppress ... ...

    Abstract Background/aim: Acute exogenous lipoid pneumonia (AELP) is a rare disorder caused by intake of lipid formulations and is often underdiagnosed. Meanwhile, the mechanism of AELP is still underlying. MCC950, was previously found to significantly suppress the release of inflammatory cytokines IL-18 and IL-1β. However, the effect of MCC950 on AELP induced by sewing machine oil has not been reported.
    Materials and methods: The NLRP3, NF-[Formula: see text]B p65, caspase-1 and IL-1β expression in lung tissues were compared between a rat model of AELP and control rats using western blotting and real-time quantitative assay. Moreover, haematoxylin and eosin (H&E) staining was performed to elucidate the mechanisms by which MCC950 ameliorates sewing machine oil-induced AELP in vivo.
    Results: MCC950 reduced the expression of NF-[Formula: see text]B p65 in the lung samples of the treatment group and further down-regulated the NLRP3 and caspase-1 levels while inhibited the production of IL-1β. Besides, decreases in inflammatory cell infiltration in the lung were shown using H&E staining.
    Conclusion: MCC950 ameliorates sewing machine oil-induced acute exogenous lipoid pneumonia in rats through inhibition of the NF-[Formula: see text]B/NLRP3 inflammasome pathway.
    MeSH term(s) Rats ; Animals ; Inflammasomes/metabolism ; NF-kappa B/metabolism ; NLR Family, Pyrin Domain-Containing 3 Protein/genetics ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Pneumonia, Lipid ; Sulfonamides/pharmacology ; Caspases
    Chemical Substances Inflammasomes ; NF-kappa B ; NLR Family, Pyrin Domain-Containing 3 Protein ; Sulfonamides ; Caspases (EC 3.4.22.-)
    Language English
    Publishing date 2023-10-30
    Publishing country Greece
    Document type Journal Article
    ZDB-ID 807031-3
    ISSN 1791-7549 ; 0258-851X
    ISSN (online) 1791-7549
    ISSN 0258-851X
    DOI 10.21873/invivo.13361
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Protective Effects of NaHS/miR-133a-3p on Lipopolysaccharide-Induced Cardiomyocytes Injury.

    Jin, Yi-Mei / Huang, Ai-Rong / Yu, Mei-Qian / Ye, Wan-Ding / Hu, Xiao-Guang / Wang, Hua-Min / Xu, Zhi-Wei / Liang, Dong-Shi

    Journal of toxicology

    2023  Volume 2023, Page(s) 2566754

    Abstract: Objective: The aim of this study was to investigate the effects of sodium hydrosulfide (NaHS) on Lipopolysaccharide (LPS)-induced cardiomyocyte injury in H9c2 cells.: Methods: H9c2 cardiomyocytes cultivated with medium containing 10 : Results: ... ...

    Abstract Objective: The aim of this study was to investigate the effects of sodium hydrosulfide (NaHS) on Lipopolysaccharide (LPS)-induced cardiomyocyte injury in H9c2 cells.
    Methods: H9c2 cardiomyocytes cultivated with medium containing 10 
    Results: Compared with the control group, the expressions of miR-133a-3p (
    Conclusion: Our research demonstrated that NaHS relieved LPS-induced myocardial injury in H9c2 by promoting the expression of miR-133a-3p, inhibiting autophagy in cardiomyocytes, and restoring cellular ATP levels.
    Language English
    Publishing date 2023-12-08
    Publishing country Egypt
    Document type Journal Article
    ZDB-ID 2495098-1
    ISSN 1687-8205 ; 1687-8191
    ISSN (online) 1687-8205
    ISSN 1687-8191
    DOI 10.1155/2023/2566754
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Pharmacokinetics of Voriconazole in Peritoneal Fluid of Critically Ill Patients.

    Lin, Xiao-Bin / Hu, Xiao-Guang / Tang, Zhao-Xia / Guo, Peng-Hao / Liu, Xiao-Man / Liang, Tao / Xia, Yan-Zhe / Lui, Ka Yin / Chen, Pan / Tang, Ke-Jing / Chen, Xiao / Cai, Chang-Jie

    Antimicrobial agents and chemotherapy

    2023  Volume 67, Issue 5, Page(s) e0172122

    Abstract: Data on the distribution of voriconazole (VRC) in the human peritoneal cavity are sparse. This prospective study aimed to describe the pharmacokinetics of intravenous VRC in the peritoneal fluid of critically ill patients. A total of 19 patients were ... ...

    Abstract Data on the distribution of voriconazole (VRC) in the human peritoneal cavity are sparse. This prospective study aimed to describe the pharmacokinetics of intravenous VRC in the peritoneal fluid of critically ill patients. A total of 19 patients were included. Individual pharmacokinetic curves, drawn after single (first dose on day 1) and multiple (steady-state) doses, displayed a slower rise and lower fluctuation of VRC concentrations in peritoneal fluid than in plasma. Good but variable penetration of VRC into the peritoneal cavity was observed, and the median (range) peritoneal fluid/plasma ratios of the area under the concentration-time curve (AUC) were 0.54 (0.34 to 0.73) and 0.67 (0.63 to 0.94) for single and multiple doses, respectively. Approximately 81% (13/16) of the VRC steady-state trough concentrations (
    MeSH term(s) Humans ; Voriconazole/pharmacokinetics ; Ascitic Fluid ; Critical Illness ; Prospective Studies ; Antifungal Agents/pharmacokinetics ; Candida glabrata ; Microbial Sensitivity Tests
    Chemical Substances Voriconazole (JFU09I87TR) ; Antifungal Agents
    Language English
    Publishing date 2023-04-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/aac.01721-22
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation.

    Lin, Xiao-Bin / Hu, Xiao-Guang / Xia, Yan-Zhe / Liu, Xiao-Man / Liang, Tao / Chen, Xiao / Cai, Chang-Jie

    Journal of chemotherapy (Florence, Italy)

    2021  Volume 34, Issue 4, Page(s) 272–276

    Abstract: The pharmacokinetics (PK) of several drugs including antimicrobials might be highly altered during extracorporeal membrane oxygenation (ECMO) therapy. We present the change of voriconazole (VRC) PK during ECMO in a critically ill patient who received ... ...

    Abstract The pharmacokinetics (PK) of several drugs including antimicrobials might be highly altered during extracorporeal membrane oxygenation (ECMO) therapy. We present the change of voriconazole (VRC) PK during ECMO in a critically ill patient who received intravenous VRC at a maintenance dose of 200 mg every 12 h for empirical antifungal therapy. Two PK profiles were drawn before and after the initiation of ECMO therapy. Though the trough levels (both
    MeSH term(s) Administration, Intravenous ; Antifungal Agents/pharmacokinetics ; Antifungal Agents/therapeutic use ; Critical Illness/therapy ; Extracorporeal Membrane Oxygenation ; Humans ; Voriconazole/therapeutic use
    Chemical Substances Antifungal Agents ; Voriconazole (JFU09I87TR)
    Language English
    Publishing date 2021-12-14
    Publishing country England
    Document type Journal Article
    ZDB-ID 1036294-0
    ISSN 1973-9478 ; 1120-009X
    ISSN (online) 1973-9478
    ISSN 1120-009X
    DOI 10.1080/1120009X.2021.2014725
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Novel photochromic infinite coordination polymer particles derived from a diarylethene photoswitch.

    Hu, Xiao Guang / Li, XiaoLiang / Yang, Sung Ik

    Chemical communications (Cambridge, England)

    2015  Volume 51, Issue 53, Page(s) 10636–10639

    Abstract: A novel infinite coordination polymer (DAE-ICP) based on zinc nitrite and a diarylethene photoswitch, with reversible photochromic properties in solution and the solid state upon applying photostimuli, was synthesized and characterized by FT-IR, EDX, FE- ... ...

    Abstract A novel infinite coordination polymer (DAE-ICP) based on zinc nitrite and a diarylethene photoswitch, with reversible photochromic properties in solution and the solid state upon applying photostimuli, was synthesized and characterized by FT-IR, EDX, FE-SEM and FE-TEM.
    Language English
    Publishing date 2015-07-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 1472881-3
    ISSN 1364-548X ; 1359-7345 ; 0009-241X
    ISSN (online) 1364-548X
    ISSN 1359-7345 ; 0009-241X
    DOI 10.1039/c5cc02447a
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: [Advances in the study of myeloid-derived suppressor cells in sepsis].

    Hu, Xiao-guang / Liu, En-he / Cai, Chang-jie

    Zhonghua wei zhong bing ji jiu yi xue

    2013  Volume 25, Issue 4, Page(s) 251–253

    MeSH term(s) Animals ; Humans ; Myeloid Cells/pathology ; Myeloid Cells/physiology ; Sepsis/pathology ; Sepsis/physiopathology
    Language Chinese
    Publishing date 2013-04
    Publishing country China
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ISSN 2095-4352
    ISSN 2095-4352
    DOI 10.3760/cma.j.issn.2095-4352.2013.04.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction.

    Lin, Xiao-Bin / Lui, Ka Yin / Guo, Peng-Hao / Liu, Xiao-Man / Liang, Tao / Hu, Xiao-Guang / Tong, Li / Wu, Jing-Jing / Xia, Yan-Zhe / Chen, Pan / Zhong, Guo-Ping / Chen, Xiao / Cai, Chang-Jie

    Pharmacotherapy

    2021  Volume 42, Issue 1, Page(s) 23–33

    Abstract: Study objectives: This study aimed to establish a population pharmacokinetic (PPK) model of intravenous voriconazole (VRC) in critically ill patients with liver dysfunction and to explore the optimal dosing strategies in specific clinical scenarios for ... ...

    Abstract Study objectives: This study aimed to establish a population pharmacokinetic (PPK) model of intravenous voriconazole (VRC) in critically ill patients with liver dysfunction and to explore the optimal dosing strategies in specific clinical scenarios for invasive fungal infections (IFIs) caused by common Aspergillus and Candida species.
    Design: Prospective pharmacokinetics study.
    Setting: The intensive care unit in a tertiary-care medical center.
    Patients: A total of 297 plasma VRC concentrations from 26 critically ill patients with liver dysfunction were included in the PPK analysis.
    Methods: Model-based simulations with therapeutic range of 2-6 mg/L as the plasma trough concentration (C
    Results: A two-compartment model with first-order elimination adequately described the data. Significant covariates in the final model were body weight on both central and peripheral distribution volume and Child-Pugh class on clearance. Intravenous VRC loading dose of 5 mg/kg every 12 h (q12h) for the first day was adequate for CP-A/B and CP-C patients to attain the C
    Conclusions: For critically ill patients with liver dysfunction, the loading dose of intravenous VRC should be reduced to 5 mg/kg q12h. Additionally, based on the types of fungal pathogens and their susceptibility to VRC, the adjusted maintenance dose regimens with lower doses or longer dosing intervals should be considered for CP-A/B and CP-C patients.
    MeSH term(s) Administration, Intravenous ; Antifungal Agents/administration & dosage ; Antifungal Agents/pharmacokinetics ; Critical Illness ; Dose-Response Relationship, Drug ; Humans ; Liver Diseases/drug therapy ; Microbial Sensitivity Tests ; Prospective Studies ; Voriconazole/administration & dosage ; Voriconazole/pharmacokinetics
    Chemical Substances Antifungal Agents ; Voriconazole (JFU09I87TR)
    Language English
    Publishing date 2021-10-25
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603158-4
    ISSN 1875-9114 ; 0277-0008
    ISSN (online) 1875-9114
    ISSN 0277-0008
    DOI 10.1002/phar.2634
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Novel photochromic infinite coordination polymer particles derived from a diarylethene photoswitch

    Hu, Xiao Guang / Li, XiaoLiang / Yang, Sung Ik

    Chemical communications. 2015 June 18, v. 51, no. 53

    2015  

    Abstract: A novel infinite coordination polymer (DAE-ICP) based on zinc nitrite and a diarylethene photoswitch, with reversible photochromic properties in solution and the solid state upon applying photostimuli, was synthesized and characterized by FT-IR, EDX, FE- ... ...

    Abstract A novel infinite coordination polymer (DAE-ICP) based on zinc nitrite and a diarylethene photoswitch, with reversible photochromic properties in solution and the solid state upon applying photostimuli, was synthesized and characterized by FT-IR, EDX, FE-SEM and FE-TEM.
    Keywords Fourier transform infrared spectroscopy ; chemical reactions ; coordination polymers ; energy-dispersive X-ray analysis ; nitrites ; scanning electron microscopy ; zinc
    Language English
    Dates of publication 2015-0618
    Size p. 10636-10639.
    Publishing place The Royal Society of Chemistry
    Document type Article
    ZDB-ID 1472881-3
    ISSN 1364-548X ; 1359-7345 ; 0009-241X
    ISSN (online) 1364-548X
    ISSN 1359-7345 ; 0009-241X
    DOI 10.1039/c5cc02447a
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article ; Online: Clinical Impacts and Outcomes With Possible Donor-Derived Infection in Infected Donor Liver Transplantation: A Single-Center Retrospective Study in China.

    Tong, Li / Hu, Xiao-Guang / Huang, Fa / Huang, Shun-Wei / Li, Li-Fen / Tang, Zhao-Xia / Yao, Ji-You / Xu, Jing-Hong / Zhu, Yan-Ping / Chen, Yin-Hua / He, Xiao-Shun / Guan, Xiang-Dong / Cai, ChangJie

    The Journal of infectious diseases

    2020  Volume 221, Issue Suppl 2, Page(s) S164–S173

    Abstract: Background: Information on possible donor-derived transmission events in China is limited. We evaluated the impacts of liver transplantation from infected deceased-donors, analyzed possible donor-derived bacterial or fungal infection events in ... ...

    Abstract Background: Information on possible donor-derived transmission events in China is limited. We evaluated the impacts of liver transplantation from infected deceased-donors, analyzed possible donor-derived bacterial or fungal infection events in recipients, and evaluated the etiologic agents' characteristics and cases outcomes.
    Methods: A single-center observational study was performed from January 2015 to March 2017 to retrospectively collect data from deceased-donors diagnosed with infection. Clinical data were recorded for each culture-positive donor and the matched liver recipient. The microorganisms were isolated and identified, and antibiotic sensitivity testing was performed. The pathogens distribution and incidence of possible donor-derived infection (P-DDI) events were analyzed and evaluated.
    Results: Information from 211 donors was collected. Of these, 82 donors were infected and classified as the donation after brain death category. Overall, 149 and 138 pathogens were isolated from 82 infected donors and 82 matched liver recipients, respectively. Gram-positive bacteria, Gram-negative bacteria, and fungi accounted for 42.3% (63 of 149), 46.3% (69 of 149), and 11.4% (17 of 149) of pathogens in infected donors. The incidence of multidrug-resistant bacteria was high and Acinetobacter baumannii was the most concerning species. Infections occurred within the first 2 weeks after liver transplantation with an organ from an infected donor. Compared with the noninfection recipient group, the infection recipient group experienced a longer mechanical ventilation time (P = .004) and intensive care unit stay (P = .003), a higher incidence of renal dysfunction (P = .026) and renal replacement therapy (P = .001), and higher hospital mortality (P = .015). Possible donor-derived infection was observed in 14.6% of cases. Recipients with acute-on-chronic liver failure were more prone to have P-DDI than recipients with other diseases (P = .007; odds ratio = 0.114; 95% confidence interval, .025-.529).
    Conclusions: When a liver recipient receives a graft from an infected deceased-donor, the postoperative incidence of infection is high and the infection interval is short. In addition, when a possible donor-derived, drug-resistant bacterial infection occurs, recipients may have serious complications and poor outcomes.
    MeSH term(s) Adolescent ; Adult ; Anti-Bacterial Agents/therapeutic use ; Bacterial Infections/prevention & control ; Bacterial Infections/transmission ; Cadaver ; China ; Drug Resistance, Multiple, Bacterial ; Female ; Humans ; Liver Transplantation/adverse effects ; Male ; Middle Aged ; Mycoses/prevention & control ; Mycoses/transmission ; Postoperative Complications/microbiology ; Retrospective Studies ; Tissue Donors ; Young Adult
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2020-03-16
    Publishing country United States
    Document type Journal Article ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jiz591
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Pharmacokinetics of intravenous voriconazole in patients with liver dysfunction: A prospective study in the intensive care unit.

    Lin, Xiao-Bin / Huang, Fa / Tong, Li / Xia, Yan-Zhe / Wu, Jing-Jing / Li, Jia / Hu, Xiao-Guang / Liang, Tao / Liu, Xiao-Man / Zhong, Guo-Ping / Cai, Chang-Jie / Chen, Xiao

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

    2020  Volume 93, Page(s) 345–352

    Abstract: Objectives: To characterize the pharmacokinetics (PK) of intravenous voriconazole (VRC) in critically ill patients with liver dysfunction.: Methods: Patients with liver dysfunction in the intensive care unit (ICU) were included prospectively. The ... ...

    Abstract Objectives: To characterize the pharmacokinetics (PK) of intravenous voriconazole (VRC) in critically ill patients with liver dysfunction.
    Methods: Patients with liver dysfunction in the intensive care unit (ICU) were included prospectively. The Child-Pugh score was used to categorize the degree of liver dysfunction. The initial intravenous VRC dosing regimen comprised a loading dose of 300 mg every 12 h for the first 24 h, followed by 200 mg every 12 h. The first PK curves (PK curve 1) were drawn within one dosing interval of the first dose for 17 patients; the second PK curves (PK curve 2) were drawn within one dosing interval after a minimum of seven doses for 12 patients. PK parameters were estimated by non-compartmental analysis.
    Results: There were good correlations between the area under the curve (AUC
    Conclusions: The CL of VRC decreased with increasing severity of liver dysfunction according to the Child-Pugh classification, along with an increased t
    MeSH term(s) Administration, Intravenous ; Adult ; Aged ; Aged, 80 and over ; Antifungal Agents/pharmacokinetics ; Area Under Curve ; Critical Illness ; Female ; Half-Life ; Humans ; Intensive Care Units ; Liver Diseases/metabolism ; Male ; Middle Aged ; Prospective Studies ; Voriconazole/administration & dosage ; Voriconazole/pharmacokinetics
    Chemical Substances Antifungal Agents ; Voriconazole (JFU09I87TR)
    Language English
    Publishing date 2020-02-25
    Publishing country Canada
    Document type Journal Article ; Observational Study
    ZDB-ID 1331197-9
    ISSN 1878-3511 ; 1201-9712
    ISSN (online) 1878-3511
    ISSN 1201-9712
    DOI 10.1016/j.ijid.2020.02.041
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top